1) Severe bone marrow suppression
重度骨髓抑制
2) severe arrest of bone marrow
骨髓重度受抑
1.
Objective To furtherly explore the main basis of differential dignosis between the severe arrest of bone marrow(SABM)and acute aplastic anemia(AAA).
目的 进一步探讨骨髓重度受抑与急性再生障碍性贫血 (简称急性再障 )之间鉴别诊断的主要依据。
3) Ⅳ grading bone marrow depression
Ⅳ度骨髓抑制
1.
Methods 31 cases of Ⅳ grading bone marrow depression induced by chemotherapy between February 1996 and April 2001 were treated with granulocyte colony stimulation factor (G-CSF) 3~5 μg/(kg·d),given hypodermic injection twice a day with an interval of 8~10 hours,lasting 5~14 days,average 8 days,combined with white cell?platelet?fres.
目的 观察粒细胞集落刺激因子 (G -CSF)在治疗化疗药物所致严重Ⅳ度骨髓抑制的疗效及毒副作用。
4) myelosuppression
骨髓抑制
1.
Abdominal pain,diarrhea and myelosuppression caused by oral methotrexate;
口服甲氨蝶呤引起腹痛、腹泻及骨髓抑制
2.
Pufferfish type Ⅰ collagen extract prevented and cured myelosuppression induced by cyclophosphamide or diamminedichloroplatinum or cytosine arabinoside in mice;
河鲀Ⅰ型胶原蛋白提取物防治环磷酰胺、顺铂或阿糖胞苷诱发小鼠骨髓抑制的研究
3.
35 Cases with AIDS Complicating Myelosuppression after HAART in the Jingyuankang Capsule;
精元康胶囊对艾滋病HAART疗法致骨髓抑制35例的临床观察
5) Bone marrow suppression
骨髓抑制
1.
Response of rhG-CSF (Rui Xuexin) in treating bone marrow suppression after concurrent chemotherapy puls radiotherapy;
瑞血新对同步放化疗后骨髓抑制的作用
2.
Treatment status of bone marrow suppression with cytokine;
生物因子治疗骨髓抑制的研究进展
3.
Severe bone marrow suppression after liver transplantation:a report of 6 cases;
肝移植术后并发严重骨髓抑制(附6例报告)
6) Bone marrow depression
骨髓抑制
1.
The effects of Thyrosin on prevention and treatment of bone marrow depression caused by chemotherapy in malignancies;
胸腺肽对肿瘤化疗病人骨髓抑制的防治作用
2.
Objective:To observe the effect of Tianjingchongsui Prescription (TP, 填 精 充 髓 方 ) on preventing bone marrow depression caused by chemotherapy.
目的观察自拟填精充髓方预防恶性肿瘤化疗患者骨髓抑制的疗效。
3.
The author here presented her theoretical and primary clinical studies on the chemotherapy- followed bone marrow depression.
本文综述了近十年来中医药治疗化疗后骨髓抑制的研究现状及进展,并系统的探讨了中西医对恶性肿瘤化疗后骨髓抑制的病因病机、治法方药。
补充资料:骨髓抑制
骨髓抑制
指药物引起的造血功能障碍。除甾体类激素、博莱霉素、长春碱类、抗癌锑、L-门冬酰胺酶等极少数抗肿瘤药物外,绝大多数抗癌药都有不同程度的骨髓抑制。其中,影响最大的是白细胞,特别是粒细胞减少最为严重,淋巴细胞受害较轻。随着用药剂量的增加,血液中三系成分均可受到影响,可出现血小板下降,严重时红细胞和血红蛋白也下降,甚至发生再生障碍性贫血。预防:①严格掌握化疗适应证;②化疗期间给与必要的支持疗法;③化疗前白细胞>4×109/L(4000/mm3),血小板>10万/dl,血红蛋白>4×109/L(10g/dl)。④化疗期间应隔日查血象1次,如白细胞<4×109/L(4000/mm3)或血小板<10万/dl,停药观察1天,如连续3天白细胞血小板未上升到上述标准,则应停药结束此疗程,待血象恢复后再开始新疗程。⑤白细胞<1×109/L(1000/mm3)时,病人应迁入无菌隔离室,以免发生感染;白细胞<5×109/L(500/mm3)时,或病人出现感染征象时,应予抗生素预防感染,并给少量多次新鲜血,刺激骨髓,增强抵抗力。血小板<20/L(2万/dl)或出现出血体征时,应给予止血药,输新鲜血或血小板。⑥集落刺激因子的应用。⑦临床上很少因化疗造成严重贫血,只有铂化合物有可能引起严重贫血而需输血。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条